Literature DB >> 29086163

Process analysis of carcinogenesis: concept derivation of the tissue function "preservation of a homogeneous gene expression".

Thomas Löser1.   

Abstract

A new system for maintaining homogeneous gene expression in tissue and for destroying through apoptosis nonconforming cells is introduced. This functionality is called the "similarity comparison." Accordingly, the survival of mutated cells is hindered due to reduced gene expression. That, in turn, maintains the homogeneity of the tissue and prevents tumors from developing. The concept of the similarity comparison is that every stationary cell in every tissue constantly screens the gene expression of its neighbors. Cells process the signals, and when the difference between neighbors exceeds some threshold, a signal is triggered. An under-expressing cell then either increases its gene expression or apoptosis occurs. The oversight role of the similarity comparison can, under certain conditions, be disrupted, such that mutated cells in the tissue can survive. This is possible only when surrounding normal cells exhibit reduced gene expression. In this case, the normal cells and mutated cells have similar gene expression, and the signal for apoptosis is not triggered. The mutated cells survive, and a tumor can develop. The importance of the similarity comparison as an oversight mechanism is studied. Examples are considered.

Entities:  

Keywords:  Complex systems; Similarity comparison; Simulation of carcinogenesis; Theoretical biology; Tissue surveillance

Mesh:

Substances:

Year:  2017        PMID: 29086163     DOI: 10.1007/s12064-017-0256-z

Source DB:  PubMed          Journal:  Theory Biosci        ISSN: 1431-7613            Impact factor:   1.919


  13 in total

1.  On somatic mutations and tissue fields in cancer: additional observations challenge the SMT.

Authors:  Daniel Satgé
Journal:  Bioessays       Date:  2011-10-05       Impact factor: 4.345

2.  SMT or TOFT? How the two main theories of carcinogenesis are made (artificially) incompatible.

Authors:  Baptiste Bedessem; Stéphanie Ruphy
Journal:  Acta Biotheor       Date:  2015-04-08       Impact factor: 1.774

Review 3.  Coming full circle-from endless complexity to simplicity and back again.

Authors:  Robert A Weinberg
Journal:  Cell       Date:  2014-03-27       Impact factor: 41.582

Review 4.  The population dynamics of cancer: a Darwinian perspective.

Authors:  Paolo Vineis; Marianne Berwick
Journal:  Int J Epidemiol       Date:  2006-09-19       Impact factor: 7.196

5.  A cancer theory kerfuffle can lead to new lines of research.

Authors:  Stuart G Baker
Journal:  J Natl Cancer Inst       Date:  2014-12-20       Impact factor: 13.506

6.  Stroma is not a major target in DMBA-mediated tumorigenesis of mouse mammary preneoplasia.

Authors:  Daniel Medina; Frances Kittrell
Journal:  J Cell Sci       Date:  2004-12-07       Impact factor: 5.285

7.  The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory.

Authors:  Ana M Soto; Carlos Sonnenschein
Journal:  Bioessays       Date:  2011-05       Impact factor: 4.345

8.  Somatic mutation theory of carcinogenesis: why it should be dropped and replaced.

Authors:  C Sonnenschein; A M Soto
Journal:  Mol Carcinog       Date:  2000-12       Impact factor: 4.784

9.  Watch thy neighbor: cancer is a communal affair.

Authors:  Valerie M Weaver; Penney Gilbert
Journal:  J Cell Sci       Date:  2004-03-15       Impact factor: 5.285

10.  Are the somatic mutation and tissue organization field theories of carcinogenesis incompatible?

Authors:  Simon Rosenfeld
Journal:  Cancer Inform       Date:  2013-12-01
View more
  1 in total

Review 1.  Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research.

Authors:  Shengming Zhu; Jiangang Wang; Lucas Zellmer; Ningzhi Xu; Mei Liu; Yun Hu; Hong Ma; Fei Deng; Wenxiu Yang; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2022-07-04       Impact factor: 4.478

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.